% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Rodrigues:281350,
author = {Rodrigues, Mark A and Seiffge, David and Samarasekera,
Neshika and Moullaali, Tom J and Wardlaw, Joanna M and
Schreiber, Stefanie and Behymer, Tyler P and Khandwala,
Vivek and Stanton, Robert J and Vagal, Vaibhav and Woo,
Daniel and Zedde, Marialuisa and Pascarella, Rosario and
Charidimou, Andreas and Warren, Andrew and Greenberg, Steven
M and Eppinger, Sebastian and Gattringer, Thomas and
Casolla, Barbara and Cordonnier, Charlotte and Werring,
David J and Al-Shahi Salman, Rustam},
collaboration = {Edinburgh CAA criteria {prognosis collaborators}},
othercontributors = {Al-Shahi Salman, Rustam and Loan, James J M and Moullaali,
Tom J and Rodrigues, Mark A and Samarasekera, Neshika and
Smith, Colin J and Wardlaw, Joanna M and Seiffge, David and
Werring, David J and Ulbrich, Philipp and Schreiber, Frank
and Schreiber, Stefanie and Pascarella, Rosario and Zedde,
Marialuisa and Charidimou, Andreas and Greenberg, Steven M
and Warren, Andrew and Behymer, Tyler and Khandwala, Vivek
and Stanton, Robert and Vagal, Vaibhav and Woo, Daniel and
Eppinger, Sebastian and Gattringer, Thomas and Boulouis,
Grégoire and Caparros, François and Casolla, Barbara and
Cordonnier, Charlotte and Dequatre-Ponchelle, Nelly and
Hénon, Hilde and Puy, Laurent and Rossi, Costanza},
title = {{A}ssociation between the {E}dinburgh {CT} and genetic
diagnostic criteria for cerebral amyloid
angiopathy-associated lobar intracerebral haemorrhage and
recurrent intracerebral haemorrhage: an individual patient
data meta-analysis.},
journal = {The lancet},
volume = {24},
number = {10},
issn = {1474-4422},
address = {London},
publisher = {Lancet Publ. Group},
reportid = {DZNE-2025-01097},
pages = {828 - 839},
year = {2025},
abstract = {Patients with lobar intracerebral haemorrhage and MRI
biomarkers of cerebral amyloid angiopathy have a greater
risk of recurrent intracerebral haemorrhage than patients
without these biomarkers. However, access to MRI is limited.
We aimed to determine whether the Edinburgh CT-only and
CT-APOE diagnostic criteria for cerebral amyloid
angiopathy-related lobar intracerebral haemorrhage are
associated with recurrent intracerebral haemorrhage.We did a
meta-analysis of individual patient data from cohort studies
identified at the 2018 International cerebral amyloid
angiopathy conference in Lille, France, assessing patients
with lobar intracerebral haemorrhage with available
diagnostic CT imaging that had been, or could be, rated for
the Edinburgh cerebral amyloid angiopathy criteria imaging
features, and with follow-up data for recurrent
intracerebral haemorrhage and death. Eligible patients were
aged 16 years or older with first or recurrent spontaneous
lobar intracerebral haemorrhage diagnosed by non-contrast
brain CT, with no evidence of an underlying cause other than
cerebral small vessel disease. Collaborators provided
individual patient-level data. The primary outcome was first
recurrent intracerebral haemorrhage occurring at least 30
days after the index event, analysed using primary two-stage
(cohort-level) and secondary one-stage (pooled)
meta-analyses with multivariable regression models with a
competing risk of death, adjusted for age, sex, and CT small
vessel disease score. Pooled analyses were adjusted for
previous intracerebral haemorrhage, dementia, hypertension,
and cohort clustering. All analyses were done in R Project
for Statistical Computing (version 4.5.0).We included eight
cohorts from Austria, France, Germany, Italy, the UK, and
the USA, with 1705 eligible patients for the CT-only
criteria. In the primary two-stage meta-analysis of the
CT-only criteria (562 patients from three European cohorts,
median age 76 years [IQR 68-82], 282 $[50\%]$ female and 280
$[50\%]$ male), 69 patients had a recurrent intracerebral
haemorrhage over 1381 person-years' follow-up. The
proportion with recurrent intracerebral haemorrhage during
5-year follow-up in the intermediate-risk and high-risk
CT-only cerebral amyloid angiopathy criteria group was 48
$(16\%)$ of 307 patients compared with 21 $(8\%)$ of 255
patients in the low-risk group (adjusted sub-distribution
hazard ratio [HR] 1·79, $95\%$ CI 1·05-3·05, p=0·032).
In the one-stage meta-analysis of the CT-only criteria (1620
patients with lobar intracerebral haemorrhage from eight
cohorts, median age 73 years [IQR 62-80], 763 $[47\%]$
female and 857 $[53\%]$ male), 171 patients had a recurrent
intracerebral haemorrhage over 3208 person-years' follow-up.
Cumulative 5-year incidence of recurrent intracerebral
haemorrhage in the low-risk CT-only cerebral amyloid
angiopathy criteria group was 45 $(12\%)$ of 727 patients
compared with 54 $(16\%)$ of 513 patients in the
intermediate-risk group (adjusted sub-distribution HR 1·68,
$95\%$ CI 1·21-2·32; p=0·0018), and 72 $(26\%)$ of 380
patients in the high-risk group (adjusted sub-distribution
HR 2·97, 1·50-5·89, p=0·0018). We included six cohorts
with 1021 eligible patients for the CT-APOE criteria; 15
patients with missing baseline data were excluded. There
were insufficient outcomes in individual CT-APOE cohorts to
do the two-stage meta-analysis. In the one-stage
meta-analysis of the CT-APOE criteria (1006 patients, median
age 71 years [IQR 58-79, 477 $[47\%]$ female and 529
$[53\%]$ male), 74 patients had a recurrent intracerebral
haemorrhage over 1495 person-years' follow-up. Cumulative
3-year incidence of recurrent intracerebral haemorrhage was
34 $(15\%)$ of 320 patients in the high-risk CT-APOE
cerebral amyloid angiopathy criteria group versus 14 $(8\%)$
of 322 patients in the low-risk group (adjusted
sub-distribution HR 2·22 $[95\%$ CI 1·36-3·61],
p=0·0014).The Edinburgh CT-only and CT-APOE diagnostic
criteria for cerebral amyloid angiopathy-associated lobar
intracerebral haemorrhage were associated with a greater
incidence of recurrent intracerebral haemorrhage. These
findings could aid personalised prediction and targeted
secondary prevention in standard clinical practice where
brain CT is available.UK Medical Research Council, The
Stroke Association, The Wellcome Trust, and The British
Heart Foundation.},
keywords = {Humans / Cerebral Amyloid Angiopathy: genetics / Cerebral
Amyloid Angiopathy: diagnostic imaging / Cerebral Amyloid
Angiopathy: complications / Cerebral Amyloid Angiopathy:
diagnosis / Cerebral Hemorrhage: diagnostic imaging /
Cerebral Hemorrhage: genetics / Cerebral Hemorrhage:
etiology / Recurrence / Male / Female / Tomography, X-Ray
Computed / Aged / Middle Aged / Cohort Studies / Aged, 80
and over / Apolipoproteins E: genetics / Apolipoproteins E
(NLM Chemicals)},
cin = {AG Schreiber},
ddc = {610},
cid = {I:(DE-2719)1310010},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40975099},
doi = {10.1016/S1474-4422(25)00285-6},
url = {https://pub.dzne.de/record/281350},
}